North Coast Journal 03-24-2022 Edition by North Coast Journal - Issuu
PDF) Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201
Pharmaceuticals | Free Full-Text | Therapeutic Strategies to Activate p53
Transposons As Tools for Functional Genomics in Vertebrate Models: Trends in Genetics
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma - Liu - 2018 - Hepatology - Wiley Online Library
Ecotropic viral integration site 1, a novel oncogene in prostate cancer | Oncogene
Full article: A therapeutic patent overview of MDM2/X-targeted therapies (2014–2018)
The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells | EMBO Molecular Medicine
vitamines, compléments, minéraux - Castres shopping
Frontiers | Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
Superoxide Ion: Generation and Chemical Implications | Chemical Reviews
EA PHARMA
Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis | Nature Communications
Mapping oncogenic protein interactions for precision medicine - Sharifi Tabar - 2022 - International Journal of Cancer - Wiley Online Library
